Clinical trial
Clinical Validation of a Simple and Fast Immunochromatographic Assay for Qualitative Determination of Specific ImmunoGLObulin IgG/IgM Antibodies to 2019- nCoV in Whole bLood, Serum or Plasma Specimen
NCT04434417 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Validation of a Simple and Fast Immunochromatographic Assay for Qualitative Determination of Specific ImmunoGLObulin IgG/IgM Antibodies to 2019- nCoV in Whole bLood, Serum or Plasma Specimen
- Lead sponsor
- European Institute of Oncology
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 15, 2020
- Completion date
- December 31, 2021
- Enrollment
- 1,000 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
covid